SARS-CoV-2 vaccine research and development: Conventional vaccines and biomimetic nanotechnology strategies

The development of a massively producible vaccine against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), a novel coronavirus, is essential for stopping the current coronavirus disease (COVID-19) pandemic. A vaccine must stimulate effective antibody and T cell responses in vivo to indu...

Descripción completa

Detalles Bibliográficos
Autores principales: Huang, Lanxiang, Rong, Yuan, Pan, Qin, Yi, Kezhen, Tang, Xuan, Zhang, Qian, Wang, Wei, Wu, Jianyuan, Wang, Fubing
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Shenyang Pharmaceutical University 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7462629/
https://www.ncbi.nlm.nih.gov/pubmed/32905011
http://dx.doi.org/10.1016/j.ajps.2020.08.001

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7462629/
https://www.ncbi.nlm.nih.gov/pubmed/32905011
http://dx.doi.org/10.1016/j.ajps.2020.08.001

Ejemplares similares